| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447171 | European Journal of Cancer | 2011 | 8 Pages |
Abstract
Type I interferons have radiosensitising effects in pancreatic cancer cell lines. This radiosensitising property might lead to an improved response to treatment in pancreatic cancer. Interferon β is the most promising drug due to its effect in clinically obtainable doses.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marjolein J.M. Morak, Peter M. van Koetsveld, Roland Kanaar, Leo J. Hofland, Casper H.J. van Eijck,